Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat‐inhibited Dopamine Transport

Journal of Neuroimmune Pharmacology(2021)10.1007/s11481-021-09984-5Source: DataRank Database

Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat‐inhibited Dopamine Transport is a research paper published in Journal of Neuroimmune Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.96)OA: hybridTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Yaxia Yuan ORCID,Yike Zhu ORCID,Yi Zhou ORCID,Matthew J. Strauss,Wei‐Lun Sun ORCID

Live enrichment

PubMed:33537927 PMC:PMC8329121 OpenAlex:https://openalex.org/W3128950729

National Institutes of Health

Grant: DA035714, DA047924

NIDA NIH HHS

Grant: R21 DA041932

NIDA NIH HHS

Grant: R01 DA047924

NIDA NIH HHS

Grant: R01 DA035714

National Institutes of Health

Grant: 5R01DA035714-07

Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine

National Institutes of Health

Grant: 5R01DA047924-04

Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS

National Institutes of Health

Grant: 1R21DA041932-01

Knock-in mouse model of dopamine transporter-Tat interaction underlying NeuroAIDS

FWCI

0.96

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s11481-021-09984-5.pdf

HYBRIDhttps://link.springer.com/content/pdf/10.1007/s11481-021-09984-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11481-021-09984-5.pdf

publisherhttps://link.springer.com/article/10.1007/s11481-021-09984-5/fulltext.html

journalhttps://doi.org/10.1007/s11481-021-09984-5

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentRNA Research and SplicingMedicine0301 basic medicine0303 health sciences03 medical and health sciencesDopamineDopamine Plasma Membrane Transport ProteinsHIV-1HumansMutationTrans-Activatorstat Gene Products, Human Immunodeficiency Virus

MeSH Terms

DopamineHumansMutationHIV-1Trans-ActivatorsDopamine Plasma Membrane Transport Proteinstat Gene Products, Human Immunodeficiency Virus

Keywords

DopamineHuman immunodeficiency virus (HIV)ChemistryBasal (medicine)PharmacologyBiophysicsBiologyNeuroscienceEndocrinologyVirologyMutationUptakeHIV-1 TatDopamine transporterComputational ModelingDopamine Plasma Membrane Transport ProteinsHIV-1Trans-ActivatorsHumansOriginal Articletat Gene Products, Human Immunodeficiency Virus

Sustainable Development Goals

SDG 0: Good health and well-being